Professional Cosmetics Peptide Supplier | GENOPEP
Myristoyl Dipeptide-13(CAS：1644362-37-7) Hair Growth Peptide
PRODUCT PARAMETERS
Description
Myristoyl Dipeptide-13 Basic Information
| Field Name | Basic information |
| INCI Name | Myristoyl Dipeptide-13 |
| CAS No. | 1644362-37-7 |
| Synonyms | Myristoyl-Glu-Trp; MYRISTOYL DIPEPTIDE-13; DermaPep™ Pepanagen |
| Key Benefits | Hair Growth |
Myristoyl Dipeptide-13 Powder Specification
| Field Name | Basic information |
| Form | Powder |
| Appearance | White to off-white powder |
| Purity (HPLC) | ≥ 95%, or ≥ 98% |
| Storage Conditions | Store sealed, protected from light and moisture. Long-term storage at -20°C is recommended. |
| Packaging | Glass/plastic sample bottles, or customized packages based on special requests. |
| Shipping | Express air freight with moisture-proof protection. |
| Inquiry | [Request a Quote / Order Samples] |
Myristoyl Dipeptide-13 Solution Specification
| Field Name | Basic information |
| Form | Liquid |
| Appearance | Clear Transparent Liquid |
| Peptide Content | 1000 ppm, 500 ppm (Customizable upon request) |
| Storage Conditions | Can transport at room temperature. Store in a dry, dark place at 2-8°C for long term storage. |
| Packaging | 1Kg or 5kg, or customized packages based on special requests. |
| Shipping | Express air freight with moisture-proof protection. |
| Sample | Request a Quote / Order Samples |
Myristoyl Dipeptide-13: Activates Wnt, FGF-7 & MITF. Prolongs anagen phase 27%, boosts density 18.3%. Anti‑hair loss lipopeptide.
Advantage and Benefit
| Feature | Details |
| Wnt/β‑Catenin Activation | Regulates Wnt signaling and inhibits TGF‑β2, prolonging the anagen phase by over 27% to reduce shedding and extend active hair growth. |
| FGF‑7 Upregulation | Increases fibroblast growth factor‑7 secretion, boosting mitotic activity in hair follicles and delivering 18.3% higher hair density after 8 weeks. |
| MITF‑Driven Melanogenesis | Activates MITF pathway and tyrosinase to enhance natural melanin deposition, ideal for anti‑graying and post‑dye color retention formulations. |
| Multi‑Cell Proliferation | Stimulates dermal papilla cells, fibroblasts, and keratinocytes simultaneously, accelerating wound healing and creating a regenerative scalp environment. |
FAQs
Q1. How does Myristoyl Dipeptide-13 prolong the anagen phase of the hair cycle at the molecular level?
A: Myristoyl Dipeptide-13 activates the Wnt/β‑catenin pathway while inhibiting TGF‑β2, a pro‑apoptotic factor that triggers catagen entry. This dual regulation prolongs the anagen phase by over 27%, as confirmed by in vitro studies on dermal papilla cells and keratinocytes. (Source: Kwon et al., 2017; SciPeptide product page)
Q2. What is the role of FGF-7 upregulation in the hair growth efficacy of Myristoyl Dipeptide-13?
A: Myristoyl Dipeptide-13 increases FGF-7 (keratinocyte growth factor) secretion, which directly stimulates mitotic activity in hair follicle cells, promoting faster cell division and thicker hair shaft formation. Clinical data shows an 18.3% increase in hair density after 8 weeks. (Source: Choi et al., 2018; SciPeptide product page)
Q3. English: How does Myristoyl Dipeptide-13 affect melanin production in hair follicles, and what formulations benefit from this property?
A: The peptide activates the MITF pathway in follicular melanocytes, upregulating tyrosinase activity to increase melanin deposition. This is particularly beneficial for post‑dye color retention products, anti‑graying treatments, and eyebrow/eyelash serums requiring natural pigmentation enhancement. (Source: Kim et al., 2015; SciPeptide product page)
GENOPEP GROUP | The Engine of Your Peptide Innovation
GENOPEP Group is a leading global peptide technology solutions provider, specializing in R&D, manufacturing, and commercialization in the fields of skin science and biopharmaceuticals. Supported by advanced scientific capabilities and a fully integrated supply chain, we deliver efficient and reliable innovation support to skincare brands worldwide.
We focus on three key service areas, empowering partners throughout the entire product lifecycle from concept to market:
- Active Ingredients and Formulation Development – Grounded in cutting-edge research, we provide high-efficacy skincare ingredients, ingredient complexes, and complete formulation solutions.
- End-to-End Production Support – Covering the full journey from lab-scale R&D and pilot optimization to commercial manufacturing, ensuring consistent product quality and reliable supply.
- Custom Synthesis Services – With strong capabilities in novel molecule development, we specialize in the design, synthesis, and preparation of peptide-based novel ingredients and related reference standards.
We believe in technology-driven products and collaboration-driven value. GENOPEP is not just a supplier—we are your trusted innovation partner, dedicated to co-creating the next generation of skincare solutions with you.
